Publicacións nas que colabora con María del Carmen Fariñas Álvarez (129)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 3, pp. 302-309

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  5. Heart transplantation as salvage treatment of intractable infective endocarditis

    Infectious Diseases, Vol. 55, Núm. 5, pp. 370-374

  6. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 77, Núm. 9, pp. 1273-1281

  7. Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections

    Frontiers in Medicine, Vol. 10

  8. Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study

    Clinical Infectious Diseases, Vol. 76, Núm. 3, pp. E995-E1003

2022

  1. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Mycoses, Vol. 65, Núm. 3, pp. 362-373

  2. Comorbidity and Prognosis in Octogenarians with Infective Endocarditis

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  3. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1452-1460

  4. Infective endocarditis in children and adolescents: a different profile with clinical implications

    Pediatric Research, Vol. 92, Núm. 5, pp. 1400-1406

  5. Multivalvular Endocarditis: A Rare Condition with Poor Prognosis

    Journal of Clinical Medicine, Vol. 11, Núm. 16

  6. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  7. Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort Study

    Frontiers in Immunology, Vol. 13

2021

  1. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2677-2699

  2. Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain

    Heart, Vol. 107, Núm. 21, pp. 1717-1724

  3. Clinical factors associated with reinfection versus relapse in infective endocarditis: Prospective cohort study

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-12

  4. Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5

  5. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection